Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com
 |
| | |
|
| Date | Title | | | 11/12/09 | Life Technologies Addresses Promise of Cell Therapies at Industry Leader Summit|
Company Hosts Cell Therapy Summit to Discuss Best Practices for
Bringing Therapeutics to Market
CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 12, 2009--
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, today is hosting the 1st
Annual Cell Therapy Industry Summit, gathering leaders from all
areas of cell therapy to discuss best practices and opportunities for
bringing potential life saving therap... |
|  | | 11/10/09 | Life Technologies Signs Definitive Agreement to Acquire BioTrove|
Acquisition enhances company’s strategic offerings in high growth
PCR market
CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 10, 2009--
Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative
life science solutions, today announced that it has signed a definitive
agreement to acquire BioTrove, Inc. for an undisclosed amount.
BioTrove’s primary technology is the OpenArray® platform, a
high throughput gene expression and ge... |
| | | 11/10/09 | University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom|
Advanced Genomic Analysis Technology to Support Genomics and
Biomedical Genetics Research
CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 10, 2009--
The University of Cambridge and Life Technologies Corporation
(NASDAQ:LIFE), announced today the formation of a collaboration to
advance translational research studies in key disease areas such as
cancer, diabetes and neurological disorders. Through this collaboration,
next generation sequencing... |
| | | 10/27/09 | Life Technologies Announces Third Quarter 2009 Results|
Third quarter GAAP revenue of $801 million, and non-GAAP revenue
of $805 million
Third quarter GAAP earnings per share of $0.22, and non-GAAP
earnings per share of $0.73
Free cash flow of $164 million in the third quarter
CARLSBAD, Calif.--(BUSINESS WIRE)--Oct. 27, 2009--
Life Technologies Corporation (NASDAQ:LIFE) today announced results for
its third quarter ended September 30, 2009. Non-GAAP revenue for the
... |
| |
|
|
| There are currently no events scheduled. |
| | |
